Home › Stocks › HCAT › All Fund Holders
HCAT — HEALTH CATALYST INC · All Fund Holders
Funds holding (latest): 46 · Reported value held: $69.88M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Marshall Wace history | Q2 2023 | 20.00M | $19.13M | 0.04% | Reduce |
| Vanguard Group history | Q4 2025 | 4.43M | $10.60M | 0.00% | Add |
| Capital Research Global Investors history | Q1 2023 | 568.78K | $6.64M | 0.00% | Hold |
| Fidelity International (FIL) history | Q4 2021 | 112.57K | $4.46M | 0.01% | Add |
| BlackRock Inc history | Q2 2026 | 1.84M | $3.65M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2022 | 240.10K | $2.55M | 0.00% | New |
| Wellington Management Group history | Q1 2025 | 2.28M | $2.29M | 0.00% | Hold |
| Tiger Global Management history | Q4 2021 | 50.00K | $1.98M | 0.00% | Hold |
| Geode Capital Management history | Q2 2026 | 891.36K | $1.77M | 0.00% | Reduce |
| Point72 Asset Management history | Q4 2024 | 215.16K | $1.52M | 0.00% | Reduce |
| Bridgewater Associates history | Q2 2023 | 107.22K | $1.34M | 0.01% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 615.50K | $1.22M | 0.00% | Add |
| MFS Investment Management history | Q2 2025 | 311.45K | $1.17M | 0.00% | Add |
| Moore Capital Management history | Q3 2025 | 398.86K | $1.14M | 0.02% | Add |
| Citadel Advisors history | Q2 2026 | 546.71K | $1.09M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 516.08K | $1.03M | 0.00% | New |
| First Eagle Investment Management history | Q2 2023 | 82.12K | $1.03M | 0.00% | Reduce |
| Baillie Gifford & Co history | Q3 2024 | 121.86K | $991.90K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 480.97K | $957.13K | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 410.64K | $817.17K | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 376.59K | $749.41K | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 349.27K | $695.04K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 254.65K | $506.76K | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2025 | 110.49K | $416.55K | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 177.16K | $352.54K | 0.00% | Reduce |
| Franklin Resources history | Q2 2025 | 80.97K | $305.27K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q4 2025 | 113.64K | $271.60K | 0.00% | Add |
| Principal Global Investors history | Q2 2025 | 62.79K | $236.72K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 106.13K | $211.20K | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 79.83K | $158.86K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2024 | 19.78K | $148.82K | 0.00% | Hold |
| CPP Investments history | Q2 2026 | 67.40K | $134.13K | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 52.46K | $104.40K | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 37.28K | $74.18K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 21.59K | $42.96K | 0.00% | Reduce |
| Manulife Financial history | Q1 2026 | 22.01K | $27.96K | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 13.71K | $27.29K | 0.00% | New |
| Prudential Financial history | Q1 2026 | 10.65K | $13.53K | 0.00% | New |
| Legal & General Investment Management America history | Q1 2026 | 6.14K | $7.80K | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 2.31K | $4.61K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 1.95K | $3.82K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 1.76K | $3.51K | 0.00% | Reduce |
| Lazard Asset Management history | Q2 2025 | 81.54K | $307 | 0.00% | Reduce |
| Arrowstreet Capital history | Q1 2023 | 25.18K | $294 | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 67.86K | $136 | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 2 | $4 | 0.00% | Reduce |